About FAKNOSTICS LLC
FAKnostics is a biotechnology company focused on developing therapeutics and diagnostics for fibrosis and cancer using FAK (Focal Adhesion Kinase) inhibition technology. Their platform targets the FAT domain of FAK, offering novel approaches to treat fibrotic diseases and inhibit cancer progression.
Development of FAK inhibitors targeting the FAT domain for fibrosis and cancer treatmentPre-clinical programs for liver, lung, and skin fibrosisCreation of FN-2012, a hydrocarbon-stapled peptide with enhanced pharmacokinetic propertiesDevelopment of FAKnosTEST, a proprietary IHC diagnostic asset for early cancer detection
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to FAKNOSTICS LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.